Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO)

British Journal of Pharmacology

Volumn 141, Issue 7, 2004, Pages 1185-1192

  Ferreira, Mônica A N D ^a   Barcelos, Lucíola S ^a   Campos, Paula P ^a   Vasconcelos, Anilton C ^a   Teixeira, Mauro M ^a   Andrade, Silvia P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chemokines; Growth factors; Neovascularization; Sponge implants

Indexed keywords

ACETYLGLUCOSAMINIDASE; CHEMOKINE; CYTOKINE; HEMOGLOBIN; MODIPAFANT; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GRANULOMA; HEMOGLOBIN ANALYSIS; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MACROPHAGE; MORPHOMETRICS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT; WILD TYPE;

ACETYLGLUCOSAMINIDASE; ADMINISTRATION, TOPICAL; ANIMALS; BLOOD VESSELS; CHEMOKINES; DIHYDROPYRIDINES; FIBROBLASTS; GRANULATION TISSUE; GRANULOMA; HEMOGLOBINS; IMIDAZOLES; IMPLANTS, EXPERIMENTAL; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; PEROXIDASE; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; POLYURETHANES; PORIFERA; RECEPTORS, G-PROTEIN-COUPLED; SKIN;

EID: 2342473827     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705731     Document Type: Article

References (38)

1. ALABASTER, V.A., KEIR, R.F., PARRY, M.J. & DE SOUZA, R.N. (1991). UK74505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo. Agents Actions (Suppl.), 34, 221-227.
2. ANDRADE, S.P., MACHADO, R.D.P., TEIXEIRA, A.S., BELO, A.V., TARSO, A.M. & BERALDO, W.T. (1997). Sponge-induced angiogenesis in mice and the pharmacological reactivity of the neovasculature quantitated by a fluorimetric method. Microvasc. Res., 54, 253-261.
3. ANDRADE, S.P., VIEIRA, L.B.G.B., BAKHLE, Y.S. & PIPER, P.J. (1992). Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse. Int. J. Exp. Pathol., 73, 503-513.
4. BAILEY, P.J. (1988). Sponge implants as models. Method Immunol., 162, 327-334.
5. BEN EZRA, D. (1978). Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants. Am. J. Ophthalmol., 86, 455-461.
6. BENNETT, S.A., LEITE, L.C. & BIRNBOIM, H.C. (1993). Platelet activating factor, an endogenous mediator of inflammation, induces phenotypic transformation of rat embryo cells. Carcinogenesis, 14, 1289-1296.
7. BROWN, L.F., DETMAR, M., CLAFFEY, K., NAGY, J.A., FENG, D., DVORAK, A.M. & DVORAK, H.F. (1997). Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Experientia Supplementum (Basel). 79, 233-269.
8. BUSSOLINO, F., ARESE, M., MONTRUCCHIO, G., BARRA, L., PRIMO, L., BENELLI, R., SANAVIO, F., AGLIETTA, M., GHIGO, D., ROLA-PLESZZCZYNSKI, M., BOSIA, A., ALBINI, A. & CAMUSSI, G. (1995). Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J. Clin. Invest., 96, 940-952.
9. CAMUSSI, G., MONTRUCCHIO, G., LUPIA, E., DE MARTINO, A., PERONA, L., ARESE, M., VERCELLONE, A., TONIOLO, A. & BUSSOLINO, F. (1995). Platelet activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J. Immunol., 154, 6492-6501.
10. DRABKIN, D.L. & AUSTIN, J.H. (1932). Spectrophotometric constants common hemoglobin derivatives in human, dog, and rabbit blood. J. Biol. Chem., 98, 719-733.
11. FRATER-SCHRÖDER, M., RISAU, W., HALLMANN, R., GAUTSCHI, P. & BÖHLEN, P. (1987). Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. U.S.A., 84, 5277-5281.
12. FOLKMAN, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med., 1, 27-31.
13. FORD, H.R., HOFFMAN, R.A., WING, E.J., MAGEE, M., MCINTYRE, L. & SIMMONS, R. (1989). Characterization of wound cytokines in the sponge matrix model. Arch. Surg., 124, 1422-1428.
14. GRIFFIOEN, A.W. & MOLEMA, G. (2000). Angiogenesis: potentials for pharmacological intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation. Pharmacol. Rev., 52, 237-268.
15. HU, D.E., HILEY, C.R., SMITHER, R.L., GRESHAM, G.A. & FAN, T.P. (1995). Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Lab. Invest., 72, 601-610.
16. ISHII, S., KUWAKI, T., NAGASE, T., MAKI, K., TASHIRO, F., SUNAGA, S., CAO, W.H., KUME, K., FUKUCHI, Y., MIYAZAKI, J., KUMADA, M. & SHIMIZU, T. (1998). Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med., 187, 1779-1788.
17. ISHII, S. & SHIMIZU, T. (2000). Platelet-activating factor (PAF) and genetically engineered PAF receptor mutant mice. Prog. Lipid Res., 39, 41-82.
18. JACKSON, J.R., BOLOGNESE, B., MANGAR, C.A., HUBBARD, W.C., MARSHALL, L.A. & WINKLER, J.D. (1998). The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. Biochem. Biophy. Acta, 1392, 145-152.
19. JACKSON, J.R., SEED, M.P., KIRCHER, C.H., WILLOUGHBY, D.A. & WINKLER, J.D. (1997). The codependence of angiogenesis and chronic inflammation. FASEB J., 11, 457-465.
20. KANAYASU, T., NAKAO-HAYASHI, J., ASUWA, N., MORITA, I., ISHII, T., ITO, H. & MUROTA, S. (1989). Leukotriene C4 stimulates angiogenesis in bovine carotid artery endothelial cells in vitro. Biochem. Biophys. Res. Commun., 159, 572-578.
21. KUME, K. & SHIMIZU, T. (1997). Platelet activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor. J. Biol. Chem., 272, 22898-22904.
22. LAGE, A.P. & ANDRADE, S.P. (2000). Assessment of angiogenesis and tumor growth in conscious mice by a fluorimetric method. Microvasc. Res., 59, 278-285.
23. MACHADO, R.D.P., FERREIRA, M.A.N.D., BELO, A.V., SANTOS, R.A.S. & ANDRADE, S.J. (2002). Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature. Regul Peptides, 107, 105-113.
24. MACHADO, R.D.P., SANTOS, R.A.S. & ANDRADE, S.P. (2001). Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis. Am. J. Physiol. Regul. Integ. Comp. Physiol., 280, R994-R1000.
25. MARRACHE, A.M., GOBEIL Jr., F., BERNIER, S.G., STANKOVA, J., ROLA-PLESZCZYNSKI, M., CHOUFANI, S., BKAILY, G., BOURDEAU, A., SIROIS, Mg., VASQUEZ-TELLO, A., FAN, L., JOYAL, J.S., FILEP, J.G., VARMA, D.R., RIBEIRO-DA-SILVA, A. & CHEMTOB, S. (2002). Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J. Immunol., 169, 6474-6481.
26. MONTRUCCHIO, G., ALLOATTI, G. & CAMUSSI, G. (2000a). Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev., 80, 1669-1699.
27. MONTRUCCHIO, G., LUPIA, E., BATTAGLIA, E., DEL SORBO, L., BOCCELLINO, M., BIACONE, L., EMANUELLI, G. & CAMUSSI, G. (2000b). Platelet-activating factor enhances VEGF-induced endothelial cell motility and neo-angiogenesis in a murine matrigel model. Arterioscler. Thromb. Vasc. Biol., 20, 80-88.
28. MORO, L., MARTINS, A.S., ALVES, C.M., SANTOS, F.G.A., NUNES, J.E.S., CARNEIRO, R.A., CARVALHO, R. & VASCONCELOS, A.C. (2003). Apoptosis in canine distemper. Arch. Virol., 148, 153-164.
29. PARRY, M.J., ALABASTER, V.A., CHEESEMAN, H.E., COOPER, K., DE SOUZA, R.N. & KEIR, R.F. (1994). Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity. J. Lipid Mediat. Cell Signal., 10, 251-268.
30. PASSANITI, A., TAYLOR, R.M., PILI, R., GUO, Y., LONG, P.V., HANEY, J.A., PAULY, R.R., GRANT, D.S. & MARTIN, G.R. (1992). A simple, quantitative method for assessing angiogenesis and antiangiogenesis agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab. Invest., 67, 519-528.
31. ROLLINS, B.J. (1997). Chemokines. Blood, 90, 909-928.
32. ROTH, M., NAUCK, M., YOUSEFI, S., TAMM, M., BLASER, K., PERRUCHOUD, A.J. & SIMON, H.U. (1996). Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J. Exp. Med., 184, 191-201.
33. SCAPINI, P., NESI, L., MORINI, M., TANGHETTI, E., BELLERI, M., NOONAN, D., PRESTA, M., ALBINI, A. & CASSATELLA, M.A. (2002). Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J. Immunol., 168 (Suppl. 11), 5798-5804.
34. SOUZA, D.O., CARA, D.C., CASSALI, G.D., COUTINHO, S.F., SILVEIRA, M.R., ANDRADE, S.P., POOLE, S.P. & TEIXEIRA, M.M. (2000). Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat. Br. J. Pharmacol., 131, 1800-1808.
35. TSOPANOGLOU, N.E., PIPILI-SYNETOS, E. & MARAGOUDAKIS, M.E. (1994). Leukotrienes C4 and D4 promote angiogenesis via a receptor-mediated interaction. Eur. J. Pharmacol., 258, 151-154.
36. VENABLE, M.E., ZIMMERMAN, G.A., McINTYRE, T.M. & PRESCOTT, S.M. (1993). Platelet-activating factor: a phospholipid autacoid with diverse actions. J. Lipid Res., 34, 691-702.
37. WILLIAMS, C.S., TSUJII, M., REESE, J., DEY, S.K. & DUBOIS, R.N. (2000). Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest., 105, 1589-1594.
38. ZHIXING, P.K., KRAVCHENKO, V.V. & YE, R.D. (1995). Platelet activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. J. Biol. Chem., 270, 7787-7790.